title: Antifibrinolytic therapy for aneurysmal subarachnoid hemorrhage: a major update of a cochrane review.
authors.affiliation: the Department of Neurology, Academic Medical Center, Amsterdam, the Netherlands. Y.B.Roos@amc.uva.nl
authors.forename: Yvo
authors.initials: Y
authors.lastname: Roos
authors.forename: Gabriel
authors.initials: G
authors.lastname: Rinkel
authors.forename: Marinus
authors.initials: M
authors.lastname: Vermeulen
authors.forename: Ale
authors.initials: A
authors.lastname: Algra
authors.forename: Jan
authors.initials: J
authors.lastname: van Gijn
mesh_terms: D000933:Antifibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002545:Brain Ischemia / Q000209:etiology; D006801:Humans; D006849:Hydrocephalus / Q000209:etiology; D016017:Odds Ratio; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D018570:Risk Assessment; D055502:Secondary Prevention; D013345:Subarachnoid Hemorrhage / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000933:Antifibrinolytic Agents